179 related articles for article (PubMed ID: 7682415)
21. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?
Fairbanks LD; Rückemann K; Qiu Y; Hawrylowicz CM; Richards DF; Swaminathan R; Kirschbaum B; Simmonds HA
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):143-52. PubMed ID: 10432311
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of CCRF-CEM human leukemic lymphoblasts by triciribine (tricyclic nucleoside, TCN, NSC-154020). Accumulation of drug in cells and comparison of effects on viability, protein synthesis and purine synthesis.
Moore EC; Hurlbert RB; Massia SP
Biochem Pharmacol; 1989 Nov; 38(22):4037-44. PubMed ID: 2480791
[TBL] [Abstract][Full Text] [Related]
23. Reversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenine.
Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ
Biochem Pharmacol; 1995 Jan; 49(1):49-56. PubMed ID: 7840782
[TBL] [Abstract][Full Text] [Related]
24. 6-Thioguanine-induced growth arrest in 6-mercaptopurine-resistant human leukemia cells.
Morgan CJ; Chawdry RN; Smith AR; Siravo-Sagraves G; Trewyn RW
Cancer Res; 1994 Oct; 54(20):5387-93. PubMed ID: 7923170
[TBL] [Abstract][Full Text] [Related]
25. Desulfuration of 6-mercaptopurine. The basis for the paradoxical cytotoxicity of thiopurines in cultured human leukemic cells.
Adamson PC; Balis FM; Hawkins ME; Murphy RF; Poplack DG
Biochem Pharmacol; 1993 Nov; 46(9):1627-36. PubMed ID: 8240420
[TBL] [Abstract][Full Text] [Related]
26. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of two enzymes in de novo purine nucleotide synthesis by triciribine phosphate (TCN-P).
Moore EC; Hurlbert RB; Boss GR; Massia SP
Biochem Pharmacol; 1989 Nov; 38(22):4045-51. PubMed ID: 2480792
[TBL] [Abstract][Full Text] [Related]
28. DNA incorporation of 6-thioguanine nucleotides during maintenance therapy of childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma.
Hedeland RL; Hvidt K; Nersting J; Rosthøj S; Dalhoff K; Lausen B; Schmiegelow K
Cancer Chemother Pharmacol; 2010 Aug; 66(3):485-91. PubMed ID: 19956952
[TBL] [Abstract][Full Text] [Related]
29. Effects of guanine ribonucleotide accumulation on the metabolism and cell cycle of human lymphoid cells.
Sidi Y; Hudson JL; Mitchell BS
Cancer Res; 1985 Oct; 45(10):4940-5. PubMed ID: 2411392
[TBL] [Abstract][Full Text] [Related]
30. Enhancement by uridine of the anabolism of 5-fluorouracil in mouse T-lymphoma (S-49) cells.
Parker WB; Klubes P
Cancer Res; 1985 Sep; 45(9):4249-56. PubMed ID: 2411399
[TBL] [Abstract][Full Text] [Related]
31. Assessment of mercaptopurine (6MP) metabolites and 6MP metabolic key-enzymes in childhood acute lymphoblastic leukemia.
Wojtuszkiewicz A; Barcelos A; Dubbelman B; De Abreu R; Brouwer C; Bökkerink JP; de Haas V; de Groot-Kruseman H; Jansen G; Kaspers GL; Cloos J; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):422-33. PubMed ID: 24940700
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of IMP dehydrogenase by mycophenolic acid in Molt F4 human malignant lymphoblasts.
Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ
Ann Clin Biochem; 1994 Mar; 31 ( Pt 2)():174-80. PubMed ID: 7914720
[TBL] [Abstract][Full Text] [Related]
33. In vitro metabolism of 6-mercaptopurine by human liver cytosol.
Rowland K; Lennard L; Lilleyman JS
Xenobiotica; 1999 Jun; 29(6):615-28. PubMed ID: 10426560
[TBL] [Abstract][Full Text] [Related]
34. On the paradoxically concentration-dependent metabolism of 6-mercaptopurine in WEHI-3b murine leukemia cells.
Liliemark J; Pettersson B; Engberg B; Lafolie P; Masquelier M; Peterson C
Cancer Res; 1990 Jan; 50(1):108-12. PubMed ID: 2293545
[TBL] [Abstract][Full Text] [Related]
35. IMP dehydrogenase inhibitors as immunomodulators.
Mitchell BS; Dayton JS; Turka LA; Thompson CB
Ann N Y Acad Sci; 1993 Jun; 685():217-24. PubMed ID: 8103312
[TBL] [Abstract][Full Text] [Related]
36. [Biochemical and clinico-pharmacological aspects of antimetabolites in the treatment of leukemia].
Bökkerink JP; de Abreu RA; Lippens RJ; Schouten TJ; de Vaan GA
Tijdschr Kindergeneeskd; 1988 Apr; 56(2):55-60. PubMed ID: 3287684
[TBL] [Abstract][Full Text] [Related]
37. The effect of thiopurine methyltransferase expression on sensitivity to thiopurine drugs.
Coulthard SA; Hogarth LA; Little M; Matheson EC; Redfern CP; Minto L; Hall AG
Mol Pharmacol; 2002 Jul; 62(1):102-9. PubMed ID: 12065760
[TBL] [Abstract][Full Text] [Related]
38. Cellular pharmacology of 6-mercaptopurine in acute lymphoblastic leukemia.
Bostrom B; Erdmann G
Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):80-6. PubMed ID: 8447563
[TBL] [Abstract][Full Text] [Related]
39. Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization.
Lilleyman JS; Lennard L; Rees CA; Morgan G; Maddocks JL
Br J Cancer; 1984 Jun; 49(6):703-7. PubMed ID: 6587901
[TBL] [Abstract][Full Text] [Related]
40. Purine nucleotide metabolism in phytohemagglutinin-induced human T lymphocytes.
Barankiewicz J; Cohen A
Arch Biochem Biophys; 1987 Oct; 258(1):167-75. PubMed ID: 2444162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]